$123 Million is the total value of Antipodean Advisors LLC's 16 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 16.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $11,553,000 | -23.1% | 67,000 | -23.0% | 9.38% | -26.0% |
BAC | Sell | BANK AMER CORP | $7,852,000 | -14.6% | 266,000 | -26.7% | 6.38% | -17.9% |
A | Sell | AGILENT TECHNOLOGIES INC | $7,099,000 | -17.5% | 106,000 | -20.9% | 5.76% | -20.6% |
MDCO | Sell | MEDICINES CO | $2,679,000 | -58.9% | 98,000 | -44.3% | 2.18% | -60.5% |
CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $2,016,000 | -91.1% | 6,000 | -90.3% | 1.64% | -91.4% |
CFCO | Exit | CF CORP | $0 | – | -740,000 | -100.0% | -6.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CARVANA CO | 21 | Q2 2023 | 38.5% |
AMAZON COM INC | 20 | Q4 2020 | 33.8% |
SEA LTD | 19 | Q3 2023 | 60.8% |
CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
MEDICINES CO | 18 | Q4 2019 | 19.8% |
ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.